About JellyArtZ

JellyArtz is a leading supplier for generic APIs. Our service, end-to-end pharmaceutical research, and development of generic API at all scales and packaging services from well known international API manufacturers with high standard, competitive pricing and detailed report without compromising the quality. JellyArtz’s vision is to grow the maturity and strength of our organization through capabilities, reliability, and sustainability to enhance the value for our stakeholders. Drive best in class customer service across everything we do through respect, understanding the customer and quality of execution.

Our Strengths

Customer Centric
At JellyArtZ, we are completely focused on our customers. We are happy to provide complete development plans advancing your preclinical drug substance candidate through regulatory approval and commercialization. Our technical consultants, led by CTO, Dr. Xiaohe Tong, are peptide experts prepared to answer your most complex peptide queries including the design of special peptides and new FRET substrates. Our customer service team is always available to provide personalized customer support from answering questions regarding a quote or tracking the status of your order.
Dependable and Responsive
Orders can be placed online or via telephone. Online ordering ensures dependable purchasing and planning. If you prefer to call CPC, our friendly and responsive customer service staff provides quotes within 24 hours and ensures on-time delivery. CPC’s commitment to data management and automated production leads to quick delivery schedules so that you can reliably schedule your research or clinical trials.




Consistent Quality Products
JellyArtZ has the expertise to design and manufacture complex peptides and can perform almost every available peptide modification. By focusing stringently on quality and cutting-edge innovation, JellyArtZ is the preferred vendor for the world’s top pharmaceutical and biotechnology companies and respected universities and research institutions throughout the world. We measure our success by the success of the researchers and clinicians using our peptides.